Lv5
870 积分 2026-03-16 加入
A Bayesian Optimal Interval Design Considering Efficacy and Toxicity in Early Phase Basket Trials
6天前
已完结
Exposure–Response Analysis to Support Nivolumab Once Every 4 Weeks Dosing in Combination with Cabozantinib in Renal Cell Carcinoma
1个月前
已完结
Population Pharmacokinetic/Pharmacodynamic Analysis of Cemdisiran (ALN-CC5) in Healthy Subjects and Patients with Immunoglobulin A Nephropathy
1个月前
已关闭
DMPK Considerations for the Development of Covalent Drugs: Insights from an IQ Assessment
1个月前
已完结
TMDD Modeling for Antibodies Directed Against Soluble Targets: Parameter Values for De Novo Modeling and Simulation From Experimental Data
2个月前
已完结
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited
2个月前
已完结
Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing?
3个月前
已完结
Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial
3个月前
已完结
Dose-Response Relationship of GLP-1 Receptor Agonists on HbA1c and Body Weight in Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis
3个月前
已完结
Optimal use of once weekly icodec insulin in type-2 diabetes: An updated meta-analysis of phase-2 and phase-3 randomized controlled trials
3个月前
已完结
皖公网安备34019202002308
